The frequency and prognostic significance of ABO/Rh blood groups in male breast cancer patients: A multicenter study

Basit Öğe Kaydı
dc.authoridGürbüz, Mustafa/0000-0001-7680-4142
dc.authoridDoğan, İzzet/0000-0003-1018-1119
dc.authoridGürbüz, Mustafa/0000-0001-7680-4142;
dc.authorwosidAy, Murat/GSI-4353-2022
dc.authorwosidGürbüz, Mustafa/JAN-6390-2023
dc.authorwosidDoğan, İzzet/AAB-6635-2020
dc.authorwosidGürbüz, Mustafa/CAJ-3354-2022
dc.authorwosidAydın, Esra/JEF-0945-2023
dc.contributor.authorDogan, Izzet
dc.contributor.authorAyhan, Murat
dc.contributor.authorGurbuz, Mustafa
dc.contributor.authorKucukarda, Ahmet
dc.contributor.authorAydin, Esra
dc.contributor.authorUrun, Yuksel
dc.contributor.authorCicin, Irfan
dc.date.accessioned2024-06-12T10:50:15Z
dc.date.available2024-06-12T10:50:15Z
dc.date.issued2022
dc.departmentTrakya Üniversitesien_US
dc.description.abstractThe study evaluated the distributions and prognostic significance of ABO and rhesus (D) groups in male breast cancer (MBC) patients. The data of 137 patients were retrospectively reviewed. Clinical, histopathological data and ABO/Rh blood groups of the patients were recorded. The ABO/Rh blood group distributions were compared to the healthy men control group (n = 120,160) by the chi-square test. Overall distributions of ABO blood groups were different between the patients (17.5% AB, 38% A, 19% B, and 25.5% O) and control group (7.88% AB, 42.06% A, 15.22% B, and 34.84% O) (P < .001). There were significant differences between the patients and control group with respect to AB vs non-AB blood group distributions (P < .001, odds ratio: 2.43, 95% CI) and O vs non-O blood group distributions (P = .016, odds ratio: 0.62, 95% CI). However, A vs non-A and B vs non-B blood group distributions were not significantly different. The distribution of the Rh factor was similar between patients and the control group (P = .93). In univariate analysis, ABO/Rh blood groups were not a prognostic factor on OS (P = .29). The frequency of the AB blood group in MBC patients is increased than in the healthy control group. AB blood group may be a risk factor for MBC, whereas O blood group may be a protective factor.en_US
dc.identifier.doi10.1097/MD.0000000000030147
dc.identifier.issn0025-7974
dc.identifier.issn1536-5964
dc.identifier.issue35en_US
dc.identifier.pmid36107512en_US
dc.identifier.scopus2-s2.0-85137805701en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.urihttps://doi.org/10.1097/MD.0000000000030147
dc.identifier.urihttps://hdl.handle.net/20.500.14551/17940
dc.identifier.volume101en_US
dc.identifier.wosWOS:000848903400009en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherLippincott Williams & Wilkinsen_US
dc.relation.ispartofMedicineen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectABO Blood Groupsen_US
dc.subjectMale Breast Canceren_US
dc.subjectPrognosisen_US
dc.subjectRisk Factorsen_US
dc.subjectGroup Antigensen_US
dc.subjectRisken_US
dc.subjectInflammationen_US
dc.subjectPopulationen_US
dc.subjectOvarianen_US
dc.subjectCohorten_US
dc.subjectAbhen_US
dc.titleThe frequency and prognostic significance of ABO/Rh blood groups in male breast cancer patients: A multicenter studyen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu